ACD and Leica Biosystems co-market RNA in situ hybridisation platform
19 August, 2014Leica Biosystems and Advanced Cell Diagnostics are co-marketing ACD's RNAscope LS ISH assays with Leica Biosystems' Bond RX research staining platform. The agreement provides researchers with an integrated and fully automated ISH solution.
Miltenyi Biotec acquires gene therapy assets from Lentigen
18 August, 2014Global biotechnology company Miltenyi Biotec has acquired the lentiviral vector manufacturing business and related assets from US company Lentigen, a provider of lentiviral technology for cell and gene therapy applications.
Baxter to sell vaccine business to Pfizer
05 August, 2014Healthcare company Baxter International has entered into a definitive agreement to sell its two commercially marketed vaccines and related production facilities to pharmaceutical company Pfizer for a total cash consideration of $635 million, subject to certain adjustments.
Thermo Fisher Scientific to distribute Newlab forensic sample processing technology
29 July, 2014Thermo Fisher Scientific has signed an agreement with NewLab Engineering, a subsidiary of Copan Italia, for the exclusive global rights to distribute card processing automation (CPA) technology, which is designed to prepare DNA samples for human identification in forensic, paternity and research laboratories.
Endomagnetics appoints Aurora BioScience as ANZ distributor
23 July, 2014UK healthcare company Endomagnetics has reached an agreement with Aurora BioScience as its exclusive distributor for Australia and New Zealand. The appointment will provide breast cancer patients in the region with access to technology that optimally locates lymph nodes as part of the cancer staging procedure in sentinel lymph node biopsy (SLNB).
IDT acquires Surveyor Nuclease business from Transgenomic
03 July, 2014Integrated DNA Technologies (IDT), a supplier of custom nucleic acids, has acquired the Surveyor enzyme business of biotech company Transgenomic.
PsS appointed Particles Plus distributor in ANZ
03 June, 2014Particle and Surface Sciences (PsS) has been appointed the sole distributor for Particles Plus throughout Australia and New Zealand. The distributorship is expected to enhance and broaden the range of particle characterisation systems already offered by PsS.
AXT appointed an official Selfrag distributor in ANZ
28 May, 2014AXT, a supplier of scientific equipment for industry and academia, has been appointed an official distributor for Selfrag in Australia and New Zealand. Selfrag designs and manufactures high-voltage pulse power fragmentation equipment for the geoscience, mining, recycling and solar industries.
AXT and Delmic sign distribution agreement
14 May, 2014Scientific equipment supplier AXT has signed an exclusive distribution agreement with Delmic, a Dutch company specialising in fluorescent/SEM (SECOM) and cathodoluminescent/SEM (SPARC) correlative microscopy technology.
Qiagen acquires biomarker for blood disorders
14 April, 2014Qiagen has acquired an exclusive worldwide licence to the biomarker calreticulin (CALR), whose mutations are found in an estimated 15% of cases of myeloproliferative neoplasms (MPNs) - a group of blood disorders involving overproduction of blood cells.
EKF acquires STI
02 April, 2014EKF Diagnostics, a global in vitro diagnostics business, has acquired Separation Technology Inc (STI), a Florida-based manufacturer of in vitro diagnostics devices for haematology testing.
GE acquires strategic assets from Thermo Fisher Scientific
26 March, 2014GE Healthcare has completed its acquisition of three businesses from Thermo Fisher Scientific: HyClone cell culture media, Dharmacon RNAi gene modulation and Sera-Mag magnetic beads.
Heidolph appoints Scitek as first ANZ premium distributor
21 March, 2014Scitek has announced its partnership with Heidolph, a German manufacturer of laboratory equipment. Heidolph has now appointed Scitek as its first premium distributor for Australia and New Zealand.
Lonza partners with Pharmacyclics to produce oncology drug
16 January, 2014Lonza, a supplier in chemical development and manufacturing, has established an agreement with Pharmacyclics to support the commercial and clinical production of its oral oncology drug Imbruvica (Ibrutinib).
TTP Labtech acquires fluorescence lifetime technology
13 January, 2014TTP Labtech has consolidated its position in the field of fluorescence lifetime (FLT) technology, having recently purchased assets from UK-based FLT company AssayMetrics.